My watch list
my.bionity.com  
Login  
NEWS
Current news

Covestro and Genomatica produce important chemical raw material using biotechnology

Breakthrough for HMDA, widely-used ingredient, paves the way for more sustainable coatings, apparel, adhesives and plastics

21-Jan-2022 Material manufacturer Covestro and biotechnology pioneer Genomatica announced an important industry milestone to advance sustainability resulting from their partnership. The two companies have teamed to be the first to successfully produce significant volumes of a plant-based version of the ... more

Agents between good and evil

Theory of narrow host range of phages challenged: consequences for phage therapy?

21-Jan-2022 Viruses that infect bacteria could one day replace antibiotics because they precisely attack only specific pathogens. Researchers at ETH Zurich are now showing that this is not always the case. This new finding is important because bacterial viruses can transfer antibiotic resistance genes. ... more

Magnesium is essential for the immune system, including in the fight against cancer

T cells need a sufficient quantity of magnesium in order to operate efficiently

21-Jan-2022 The level of magnesium in the blood is an important factor in the immune system’s ability to tackle pathogens and cancer cells. Writing in the journal Cell, researchers from the University of Basel and University Hospital Basel have reported that T cells need a sufficient quantity of magnes ... more

Does coffee help protect against endometrial cancer?

Caffeinated coffee may provide better protection than decaffeinated coffee

21-Jan-2022 Higher coffee consumption is linked with a lower risk of endometrial cancer, a type of cancer that begins in the lining of uterus, according to an analysis of relevant studies published to date. Also, caffeinated coffee may provide better protection than decaffeinated coffee. The analysis, ... more

Machine learning model uses blood tests to predict COVID-19 survival

Levels of 14 proteins in the blood of critically ill COVID-19 patients are associated with survival

21-Jan-2022 A single blood sample from a critically ill COVID-19 patient can be analyzed by a machine learning model which uses blood plasma proteins to predict survival, weeks before the outcome, according to a new study published in the open-access journal PLOS Digital Health by Florian Kurth and Mar ... more

Deadly spider venom as a basic ingredient of medical applications?

Mystery of the Black Widow decoded

20-Jan-2022 The black widow snatches its prey with venom. The bite of the spider can also be fatal for humans. Until now, it was unclear how the neurotoxin is structured exactly and how it works in detail. The research groups of Professor Richard Wagner, biophysicist at Jacobs University Bremen, and Pr ... more

Bruker Acquires Prolab Instruments

Augment Multiomics Solutions

20-Jan-2022 Bruker Corporation announced the acquisition of Prolab Instruments GmbH, a Swiss technology company specialized in low-flow, high precision liquid chromatography technology and systems. Financial terms of the transaction were not disclosed. Mr. Werner Doebelin, the Founder and CEO of Prolab ... more

Vetter’s new clinical manufacturing site now officially authorized

Additional filling capacities for early-stage clinical development

20-Jan-2022 Vetter has received the manufacturing authorization for its new site in Rankweil, Austria. As a result of the successful inspection held by the responsible national regulatory authority, the Austrian Agency for Health and Food Safety (AGES), the site can now support clinical development pro ... more

A herpes virus as a vaccination helper

Research team develops novel corona and flu vaccination based on cytomegalovirus

20-Jan-2022 Viruses are mostly encountered as pathogens. However, virus-based vaccination platforms can also help to provide protection from different diseases. In a mouse model, researchers from the Helmholtz Centre for Infection Research (HZI) in Braunschweig together with national and international ... more

Learning from dust: health risks of microparticles

Properties such as size, shape and surface condition of microparticles influence their hazardous potential for humans

20-Jan-2022 Researchers at the University of Bayreuth want to find out the consequences of inhaled microplastics. In order to better understand them, they have conducted an interdisciplinary study to find out how the health risks of particles such as soot, grinding dust or asbestos are related to their ... more

All news

Bruker Acquires Prolab Instruments

Augment Multiomics Solutions

20-Jan-2022 Bruker Corporation announced the acquisition of Prolab Instruments GmbH, a Swiss technology company specialized in low-flow, high precision liquid chromatography technology and systems. Financial terms of the transaction were not disclosed. Mr. Werner Doebelin, the Founder and CEO of Prolab ... more

Seeing inside cells with an integrated nanowire probe

Real-time, in-situ sensing and tracking of cell development and maturation is achieved using a label-free nano-optical device

20-Jan-2022 The biological intracellular microenvironment is complex, made up of various cell compartments and intracellular substances. To fully characterize the physiological function of living cells, one of the key factors is the development of micro/nanoprobes for subcellular measurement. Current n ... more

Finding the invisible

Researchers have developed a method to extract more information from sequencing data

12-Jan-2022 Higher organisms store their genetic material in the nuclei of cells as deoxyribonucleic acid (DNA). In a process called transcription, individual segments, the genes, are converted into messenger ribonucleic acids (mRNAs). Subsequently, the translation process produces proteins as the most ... more

Life-science start-up Actome and QIAGEN announce commercial partnership

Licensing and co-marketing agreement signed

11-Jan-2022 Actome GmbH, a life-science start-up company from the University of Freiburg and Hahn-Schickard, Germany has signed a license agreement and a co-marketing agreement with QIAGEN GmbH, Hilden, Germany, to jointly accelerate the market entry of Actome’s Protein-Interaction-Coupling (PICO) Tech ... more

Which animals exist right here? Now researchers are able to find the answer out of thin air

Researchers have found a way to collect samples of animal DNA from the air with a new method

10-Jan-2022 Identifying the animal species that live in a particular area can be a lot of work. Usually it means spotting the animals with the naked eye or recording them using a camera trap. Their presence can also be identified via the traces they leave on the ground or in the form of e.g. faeces. Co ... more

DNA in archaeological sediments

Ancient human and animal DNA can remain stably localized in sediments, preserved in microscopic fragments of bone and feces

06-Jan-2022 The analysis of ancient DNA preserved in sediments is an emerging technology allowing for the detection of the past presence of humans and other animals at archaeological sites. Yet, little is known about how DNA is preserved in sediment for long periods of time. An international team of re ... more

Taking Microbes Out of Dark and Into the Light

Research Alliance Develops New Methods for Screening and Cultivating Biotechnologically Promising Microorganisms

03-Jan-2022 Microorganisms are the oldest, most abundant, and most diverse life forms on earth and offer enormous potential for biotechnological applications. To date, however, only a fraction of them could be isolated and cultivated. The “MicroMATRIX” research project, funded with EUR 1.5 million by t ... more

Pioneering new technique to barcode cells

New method, that combines artificial intelligence with microfluidics, that can easily classify, sort and count individual cells

21-Dec-2021 Scientists have developed a pioneering new technique to barcode individual cells more accurately and efficiently - which could help pave the way for quicker disease diagnosis.  A team of researchers from the Living Systems Institute at the University of Exeter has created a new method, that ... more

Sartorius strengthens its bioanalytics portfolio by acquiring a majority stake in ALS Automated Lab Solutions

17-Dec-2021 The life science group Sartorius is expanding its bioanalytics portfolio by acquiring a majority stake in ALS Automated Lab Solutions GmbH. The laboratory technology company based in Jena, Germany, develops, manufactures and markets solutions for the automated analysis, selection and isolat ... more

Biodiversity Discovery 4.0 for Everyone

Cutting-edge sequencing technology fit in any trouser pocket

08-Dec-2021 Scientists at the Museum für Naturkunde Berlin, together with colleagues from the National University of Singapore, have succeeded in optimizing and simplifying a method of species identification using a genetic "barcode" system and a small inexpensive sequencing device. The new approach re ... more

All news on bioanalytics

Covestro and Genomatica produce important chemical raw material using biotechnology

Breakthrough for HMDA, widely-used ingredient, paves the way for more sustainable coatings, apparel, adhesives and plastics

21-Jan-2022 Material manufacturer Covestro and biotechnology pioneer Genomatica announced an important industry milestone to advance sustainability resulting from their partnership. The two companies have teamed to be the first to successfully produce significant volumes of a plant-based version of the ... more

Agents between good and evil

Theory of narrow host range of phages challenged: consequences for phage therapy?

21-Jan-2022 Viruses that infect bacteria could one day replace antibiotics because they precisely attack only specific pathogens. Researchers at ETH Zurich are now showing that this is not always the case. This new finding is important because bacterial viruses can transfer antibiotic resistance genes. ... more

PreOmics announces early investors’ exit and closing of Series B financing

Bruker is now a majority investor in PreOmics

19-Jan-2022 PreOmics GmbH, a Martinsried, Germany-based developer of innovative automation and sample preparation tools and consumables for unbiased, deep proteomics analysis by mass spectrometry, has raised €13.5m in a Series B financing round provided by Bruker Corporation. PreOmics was founded in 20 ... more

The two startups NeoCura and PhoreMost announce research collaboration to explore novel cancer therapeutics

19-Jan-2022 NeoCura Bio-Medical Technology Co., Ltd., a RNA-based drug research and development company in China, and PhoreMost Limited, the UK-based biopharmaceutical company dedicated to ‘Drugging the Undruggable®’, announced an oncology drug discovery research collaboration As part of the collaborat ... more

CureVac Chief Technology Officer to Pursue New Career outside Biotech Industry

Dr. Mariola Fotin-Mleczek will resign from CureVac

18-Jan-2022 CureVac N.V. announced that the company’s Chief Technology Officer, Dr. Mariola Fotin-Mleczek, will resign from CureVac effective January 31, 2022. Mariola exits her role at CureVac after nearly 16 years of scientific leadership at the company, and 33 years in Germany, with plans to pursue ... more

Evonik builds world's first industrial-scale production plant for rhamnolipids

Fermentation of sugar replaces petrochemical raw materials

18-Jan-2022 Evonik is investing a three-digit million-euro sum in the construction of a new production plant for bio-based and fully biodegradable rhamnolipids. The decision to build the plant follows a breakthrough in Evonik's research and development. Rhamnolipids are biosurfactants and serve as acti ... more

A spray to protect against lung damage from Covid-19

Startup develop an RNA-based drug

18-Jan-2022 rnatics, a startup at the Technical University of Munich (TUM), has created an RNA-based drug to prevent lung damage from infections as seen in serious Covid-19 cases. The Federal Ministry of Education and Research (BMBF) is providing 7 million euros in funding to support the development of ... more

Turning harmful carbon dioxide into useful chemicals

Inspired by nature: Electro-biocatalytic CO₂ fixing replaces fossil resources

14-Jan-2022 Making important raw materials for fine chemicals out of carbon dioxide really works. As part of the Max Planck collaborative project eBioCO2n, a team of researchers from Fraunhofer IGB have successfully performed a first ever fixation of CO2 via a multi-enzyme enzyme reaction driven by ele ... more

Unmuting the genome

Epigenetic mechanisms for parent-specific genetic activation decoded

13-Jan-2022 Hereditary diseases as well as cancers and cardiovascular diseases may be associated with a phenomenon known as genomic imprinting, in which only the maternally or paternally inherited gene is active. An international research team involving scientists at the Technical University of Munich ... more

Pantherna Therapeutics secures EUR 4.0 Mio. follow-on financing to advance its therapeutic mRNA development programs  

13-Jan-2022 Pantherna Therapeutics announces the successful completion of a follow-on financing round totaling EUR 4.0 Mio. led by existing investors Riesner Verwaltungs GmbH and High-Tech Gründerfonds. The proceeds of this round will be used to accelerate preclinical development activities for its lea ... more

All news on biotechnology

Machine learning model uses blood tests to predict COVID-19 survival

Levels of 14 proteins in the blood of critically ill COVID-19 patients are associated with survival

21-Jan-2022 A single blood sample from a critically ill COVID-19 patient can be analyzed by a machine learning model which uses blood plasma proteins to predict survival, weeks before the outcome, according to a new study published in the open-access journal PLOS Digital Health by Florian Kurth and Mar ... more

Lifespin secures bridge financing

Artificial intelligence to determine health status and diagnose diseases

18-Jan-2022 Lifespin GmbH in BioPark Regensburg has successfully concluded bridge financing to a total of € 2.5 million. The diagnostic data company is working successfully on an AI-based health platform that can measure important metabolic parameters in patients and expects to start series A in the fu ... more

AI offers a faster way to predict antibiotic resistance

Huge new data set combines mass spectrometry data with information on antibiotic resistance

14-Jan-2022 A study under co-leadership of the ETH Zurich has shown that computer algorithms can determine antimicrobial resistance of bacteria faster than previous methods. This could help treat serious infections more efficiently in the future. Antibiotic-resistant bacteria are on the rise all over t ... more

PCR: Activated by light

New approach could help to significantly improve diagnostic tests based on PCR

20-Dec-2021 DNA polymerases and other enzymes that modify DNA are essential tools in biotechnology and diagnostics. They are the key component for COVID-19 diagnostics by PCR. As useful as they are, DNA processing enzymes often have important flaws. Some of them display significant activity during the ... more

Startup revolutionizes diagnostics in dermatology

Dermagnostix closes seven-figure seed round

17-Dec-2021 Dermagnostix revolutionizes diagnostics in dermatology with its fully auto-mated "lab-in-a-box" system, which allows the technically valid performance of complex molecular assays. "Modern molecular diagnostics is a prerequisite for implementing precision medicine in dermatology. It not only ... more

Spoiled oranges shine light on malignant cells

Biomedical device passes the litmus test

16-Dec-2021 A University of Sydney PhD researcher is developing a cancer and serious disease-detecting biomedical probe that can be made from the juice of rancid oranges. Called a nanobiosensor – a tiny probe that uses fluorescence to signal cells' pH in terms of their acidity or alkalinity – it detect ... more

Seasonal temperature impacts patient lab results

14-Dec-2021 Ambient temperature influences the results of some of the most used laboratory tests, and these distortions likely affect medical decision making, such as whether to prescribe medications, researchers report December 10th in the journal Med. The authors say that laboratories could statistic ... more

Rapid PCR tests at the touch of a button

ETH start-​up diaxxo hope to fundamentally change the way in which PCR testing is deployed in medicine

14-Dec-2021 ETH researchers Michele Gregorini and Philippe Bechtold have developed a PCR testing device that can easily be used outside the lab – and that takes less than 30 minutes to deliver results. Now the two young entrepreneurs are focusing their efforts on getting the device approved for medical ... more

New marker for better assessing the severity of Covid-19

Scientists have found a new marker in the blood of Covid-19 patients. It furnishes insights into the course and development of the disease and could lead to better diagnoses

08-Dec-2021 Many people infected with SARS-CoV-2 are either asymptomatic or feel only slightly unwell. Nevertheless, the infections can produce the clinical picture of Covid-19, including inflammations and changes to blood coagulation. Moreover, doctors have observed disorders of the immune system in C ... more

COVID-19 : Measuring viral RNA to predict which patients will die

A statistical model uses a blood biomarker of SARS-CoV-2 to identify infected patients who are most at risk of dying of COVID-19

30-Nov-2021 The amount of a SARS-CoV-2 genetic material—viral RNA—in the blood is a reliable indicator in detecting which patients will die of the disease, a team led by Université de Montréal medical professor Dr. Daniel Kaufmann has found. The finding is published in Science Advances. Kaufmann and hi ... more

All news on diagnostics

Eppendorf AG completes conversion to European public limited company

Group headquarter remains in Hamburg, Germany

21-Oct-2021 The internationally active life science company Eppendorf, headquartered in Hamburg, Germany, has completed its conversion to the European legal form Societas Europaea (SE) as of October 19, 2021. The company will operate as Eppendorf SE with immediate effect. "We are convinced that we have ... more

Gloves with a double barrier function and perforation indicator help reduce the risk of injury and infection

MedTech startup Smarterials Technology closes second seed financing round

29-Sep-2021 Smarterials Technology GmbH has successfully closed its second round of financing. Led by High-Tech Gründerfonds (HTGF), pre-seed investors Think.Health Ventures and Emanet also invest a total of nearly €1 million in the Berlin-based company. The new funding will be used to complete final d ... more

Tecan successfully completes the acquisition of Paramit

05-Aug-2021 The Tecan Group  announced that it has successfully completed the acquisition of US-based Paramit Corporation and its affiliates (“Paramit”) for a total purchase consideration of USD 1.0 billion (CHF 920 million). On June 23, 2021, Tecan entered into a definitive agreement to acquire Parami ... more

Sartorius continues on its fast growth trajectory

Significant double-digit increases in sales and earnings

22-Jul-2021 Sartorius has continued on its fast growth trajectory, closing the first half of 2021 with significant double-digit increases in both sales revenue and order intake. “In the first six months of the year, we have seen unabated high demand for innovative technologies used in the development a ... more

Simplified method for calibrating optical tweezers

Broadband measurement of viscoelasticity with reduced measurement time

20-Jul-2021 Measurements of biomechanical properties inside living cells require minimally invasive methods. Optical tweezers are particularly attractive as a tool. It uses the momentum of light to trap and manipulate micro- or nanoscale particles. A team of researchers led by Prof. Dr. Cornelia Denz f ... more

OLS OMNI Life Science and Namocell sign distribution agreement

Single cell sorting and dispensing instruments now available in Germany and Austria

13-Jul-2021 OLS OMNI Life Science announced a distribution agreement with Namocell Inc., a provider of high-performance single cell sorting and dispensing platforms. As of now on OLS OMNI Life Science offers an expanded cell research portfolio focused next to single cell sorting and dispensing on cell ... more

Francisco Partners to Acquire STARLIMS

08-Jul-2021 Francisco Partners, a leading global investment firm that specializes in partnering with technology businesses, announced that it has signed a definitive agreement to acquire the STARLIMS informatics product suite and related business assets from Abbott. Terms of the transaction were not di ... more

Remote-controlled labs - Lab of the future is liberating scientists from the limitations of their location

California-based startup Strateos closes $56 Million Series B financing

10-Jun-2021 Strateos, Inc., a pioneer in the development of remote access laboratories and lab control software for life science research, announced the closing of its $56.1 million Series B financing led by DCVC and Lux Capital with participation from new investors including Eli Lilly and Company, All ... more

An AI Robot for Pipetting

Researchers from the University of Freiburg have received an EXIST grant for their goodBot startup

31-May-2021 Pipettes are important tools for scientists when transporting liquids in medical, pharmaceutical, biology, and chemistry laboratories. Using pipettes precisely is especially important when repeating experiments. The University of Freiburg researchers Julius Wiener, Tobias Zundel, and Oliver ... more

PerkinElmer to Acquire Nexcelom Bioscience

14-May-2021 PerkinElmer, Inc. announced it has entered into an agreement to acquire Nexcelom Bioscience for $260 Million in cash. The transaction is expected to close during the second quarter of 2021.Nexcelom is a global provider of automated cell counting instruments, image cytometry workstations, as ... more

All news on laboratory equipment / laboratory supplies

Vetter’s new clinical manufacturing site now officially authorized

Additional filling capacities for early-stage clinical development

20-Jan-2022 Vetter has received the manufacturing authorization for its new site in Rankweil, Austria. As a result of the successful inspection held by the responsible national regulatory authority, the Austrian Agency for Health and Food Safety (AGES), the site can now support clinical development pro ... more

The two startups NeoCura and PhoreMost announce research collaboration to explore novel cancer therapeutics

19-Jan-2022 NeoCura Bio-Medical Technology Co., Ltd., a RNA-based drug research and development company in China, and PhoreMost Limited, the UK-based biopharmaceutical company dedicated to ‘Drugging the Undruggable®’, announced an oncology drug discovery research collaboration As part of the collaborat ... more

Evotec and Lilly enter into drug discovery collaboration in metabolic diseases

Lilly has the right to select up to five programmes

19-Jan-2022 Evotec SE announced that the Company has entered into a drug discovery collaboration with Eli Lilly and Company in the field of metabolic diseases with a focus on kidney diseases and diabetes.  The collaboration leverages Evotec’s extensive experience and track record of delivering in the f ... more

A spray to protect against lung damage from Covid-19

Startup develop an RNA-based drug

18-Jan-2022 rnatics, a startup at the Technical University of Munich (TUM), has created an RNA-based drug to prevent lung damage from infections as seen in serious Covid-19 cases. The Federal Ministry of Education and Research (BMBF) is providing 7 million euros in funding to support the development of ... more

Pantherna Therapeutics secures EUR 4.0 Mio. follow-on financing to advance its therapeutic mRNA development programs  

13-Jan-2022 Pantherna Therapeutics announces the successful completion of a follow-on financing round totaling EUR 4.0 Mio. led by existing investors Riesner Verwaltungs GmbH and High-Tech Gründerfonds. The proceeds of this round will be used to accelerate preclinical development activities for its lea ... more

AI-enabled drug research reduces time and cost of drug development

Debiopharm invests in VeriSIM Life’s $15m series A round

12-Jan-2022 Debiopharm, a Swiss biopharmaceutical company, announced their co-investment in California-based start-upVeriSIM Life’s $15 Million Series A Round to advance their mission to accelerate drug development via technology powered by artificial intelligence (AI). VeriSIM Life’s computational pla ... more

BioNTech and Crescendo Biologics Announce Global Collaboration to Develop Multi-specific Precision Immunotherapies

Crescendo will receive $40 million upfront, including a cash payment and an equity investment from BioNTech

11-Jan-2022 BioNTech SE and Crescendo Biologics Ltd, a clinical stage immuno-oncology company developing novel, targeted T cell enhancing therapeutics, announced that they have entered a multi-target discovery collaboration to develop novel immunotherapies for the treatment of patients with cancer and ... more

Definitive Agreement to Acquire Exelead will Strengthen Merck’s CDMO Offering for mRNA

Targeted acquisition to accelerate novel modalities service offering

07-Jan-2022 Merck has signed a definitive agreement to acquire Exelead, a biopharmaceutical contract development and manufacturing organization (CDMO), for approximately USD 780 million in cash. Exelead specializes in complex injectable formulations, including Lipid Nanoparticle (LNP) based drug delive ... more

COVID-19 Oral Vaccine and Antibody Booster

Biotechnology Breakthrough by start-up DreamTec

06-Jan-2022 Vaccines have been a trending topic ever since the coronavirus outbreak two years ago. DreamTec Research Limited has its major breakthrough in developing a COVID-19 oral vaccine. In its recently published peer-reviewed paper in an international medical journal Vaccines, which demonstrates B ... more

PhoreMost and POLARISqb announce a multi-target collaboration to investigate next-generation cancer therapies

Start-ups combine biotechnology and artificial intelligence

06-Jan-2022 PhoreMost Limited, a UK-based biopharmaceutical company dedicated to developing drugs against intractable disease targets, and Polaris Quantum Biotech (POLARISqb), a NC-based quantum computing drug design company, announced a collaboration to study oncology targets currently considered undr ... more

All news on pharma

Agents between good and evil

Theory of narrow host range of phages challenged: consequences for phage therapy?

21-Jan-2022 Viruses that infect bacteria could one day replace antibiotics because they precisely attack only specific pathogens. Researchers at ETH Zurich are now showing that this is not always the case. This new finding is important because bacterial viruses can transfer antibiotic resistance genes. ... more

Magnesium is essential for the immune system, including in the fight against cancer

T cells need a sufficient quantity of magnesium in order to operate efficiently

21-Jan-2022 The level of magnesium in the blood is an important factor in the immune system’s ability to tackle pathogens and cancer cells. Writing in the journal Cell, researchers from the University of Basel and University Hospital Basel have reported that T cells need a sufficient quantity of magnes ... more

Does coffee help protect against endometrial cancer?

Caffeinated coffee may provide better protection than decaffeinated coffee

21-Jan-2022 Higher coffee consumption is linked with a lower risk of endometrial cancer, a type of cancer that begins in the lining of uterus, according to an analysis of relevant studies published to date. Also, caffeinated coffee may provide better protection than decaffeinated coffee. The analysis, ... more

Deadly spider venom as a basic ingredient of medical applications?

Mystery of the Black Widow decoded

20-Jan-2022 The black widow snatches its prey with venom. The bite of the spider can also be fatal for humans. Until now, it was unclear how the neurotoxin is structured exactly and how it works in detail. The research groups of Professor Richard Wagner, biophysicist at Jacobs University Bremen, and Pr ... more

A herpes virus as a vaccination helper

Research team develops novel corona and flu vaccination based on cytomegalovirus

20-Jan-2022 Viruses are mostly encountered as pathogens. However, virus-based vaccination platforms can also help to provide protection from different diseases. In a mouse model, researchers from the Helmholtz Centre for Infection Research (HZI) in Braunschweig together with national and international ... more

Learning from dust: health risks of microparticles

Properties such as size, shape and surface condition of microparticles influence their hazardous potential for humans

20-Jan-2022 Researchers at the University of Bayreuth want to find out the consequences of inhaled microplastics. In order to better understand them, they have conducted an interdisciplinary study to find out how the health risks of particles such as soot, grinding dust or asbestos are related to their ... more

Forever Young: a new genetic brake for an ageing immune system

A Parkinson’s disease gene turns out to provide the key to modify diseases related to immunoageing

19-Jan-2022 In a world with an ageing global population, we could all use some good news when it comes to age-related health. The latest findings in a study led by Dr Feng Hefeng at the Luxembourg Institute of Health’s (LIH) Immune Systems Biology Group could be just the tonic, having identified surpri ... more

Scientists dive deep into the different effects of morning and evening exercise

Using exercise to fix a faulty body clock

18-Jan-2022 Exercise causes the body to release hundreds of different signals that improve our health in many different ways. Now scientists have mapped these intrinsic signals and how they are released by different organs in mice following exercise at different times of the day. Their ‘Atlas of Exerci ... more

Sniffer Dog for Drug Degradation Products

Deuteriation: Hot Topic in Chemical Research

17-Jan-2022 Drugs that we take are chemically altered as they are degraded in the body. In the case of newly developed active ingredients it is important to know which degradation products (metabolites) are formed in the process, because these can be incompatible or even harmful. To detect such metabol ... more

Researchers lay groundwork for potential dog-allergy vaccine

Scientists have identified a series of molecular candidates for those parts of dog allergens that cause immune reactions in people

17-Jan-2022 There have been many research efforts describing the nature and progression of dog allergies, but there have been very few applied studies that use this information to try to cure people of dog allergies entirely by artificially inducing immune tolerance. But researchers have now for the fi ... more

All news on healthcare
News by department
  • Products

    Covestro and Genomatica produce important chemical raw material using biotechnology

    Breakthrough for HMDA, widely-used ingredient, paves the way for more sustainable coatings, apparel, adhesives and plastics

    21-Jan-2022 Material manufacturer Covestro and biotechnology pioneer Genomatica announced an important industry milestone to advance sustainability resulting from their partnership. The two companies have teamed to be the first to successfully produce significant volumes of a plant-based version of the ... more

    A spray to protect against lung damage from Covid-19

    Startup develop an RNA-based drug

    18-Jan-2022 rnatics, a startup at the Technical University of Munich (TUM), has created an RNA-based drug to prevent lung damage from infections as seen in serious Covid-19 cases. The Federal Ministry of Education and Research (BMBF) is providing 7 million euros in funding to support the development of ... more

    Pantherna Therapeutics secures EUR 4.0 Mio. follow-on financing to advance its therapeutic mRNA development programs  

    13-Jan-2022 Pantherna Therapeutics announces the successful completion of a follow-on financing round totaling EUR 4.0 Mio. led by existing investors Riesner Verwaltungs GmbH and High-Tech Gründerfonds. The proceeds of this round will be used to accelerate preclinical development activities for its lea ... more

  • Business

    Bruker Acquires Prolab Instruments

    Augment Multiomics Solutions

    20-Jan-2022 Bruker Corporation announced the acquisition of Prolab Instruments GmbH, a Swiss technology company specialized in low-flow, high precision liquid chromatography technology and systems. Financial terms of the transaction were not disclosed. Mr. Werner Doebelin, the Founder and CEO of Prolab ... more

    Definitive Agreement to Acquire Exelead will Strengthen Merck’s CDMO Offering for mRNA

    Targeted acquisition to accelerate novel modalities service offering

    07-Jan-2022 Merck has signed a definitive agreement to acquire Exelead, a biopharmaceutical contract development and manufacturing organization (CDMO), for approximately USD 780 million in cash. Exelead specializes in complex injectable formulations, including Lipid Nanoparticle (LNP) based drug delive ... more

    Sanofi to acquire Amunix immuno-oncology pipeline with next generation Conditionally Activated Biologics

    22-Dec-2021 Sanofi announced that it has entered into an agreement to acquire Amunix Pharmaceuticals, Inc., an immuno-oncology company leveraging its proprietary, clinically validated XTEN® and innovative universal protease-releasable masking technology platform, Pro-XTENTM, to discover and develop tra ... more

  • Price Development

    Are the high prices of cancer drugs justified?

    Does the cost correspond to the particular drug’s effectiveness in combating the disease?

    05-May-2020 Do high prices of some cancer medicines have a higher benefit than those drugs with lower prices? An international UZH study has concluded that, in general, there is no correlation between costs of a cancer drugs and their clinical benefit. The researchers are therefore calling for the clin ... more

    Drug costs vary by more than 600% in study of 10 high-income countries

    13-Jun-2017 In a study of 10 high-income countries with universal health care, costs for prescription drugs in 6 of the largest categories of primary care medicines varied by more than 600%. All countries except Canada offered universal coverage of outpatient prescription drugs. The study looked at dat ... more

    Cell Medica granted Orphan Drug designation for novel cellular therapy

    18-Mar-2015 Cell Medica announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to the company’s cancer immunotherapy treatment, referred to as CMD-003, under development for Epstein-Barr Virus (EBV) positive non-Hodgkin lymphomas. Additionally, the company announ ... more

  • Research

    Agents between good and evil

    Theory of narrow host range of phages challenged: consequences for phage therapy?

    21-Jan-2022 Viruses that infect bacteria could one day replace antibiotics because they precisely attack only specific pathogens. Researchers at ETH Zurich are now showing that this is not always the case. This new finding is important because bacterial viruses can transfer antibiotic resistance genes. ... more

    Magnesium is essential for the immune system, including in the fight against cancer

    T cells need a sufficient quantity of magnesium in order to operate efficiently

    21-Jan-2022 The level of magnesium in the blood is an important factor in the immune system’s ability to tackle pathogens and cancer cells. Writing in the journal Cell, researchers from the University of Basel and University Hospital Basel have reported that T cells need a sufficient quantity of magnes ... more

    Does coffee help protect against endometrial cancer?

    Caffeinated coffee may provide better protection than decaffeinated coffee

    21-Jan-2022 Higher coffee consumption is linked with a lower risk of endometrial cancer, a type of cancer that begins in the lining of uterus, according to an analysis of relevant studies published to date. Also, caffeinated coffee may provide better protection than decaffeinated coffee. The analysis, ... more

  • People

    CureVac Chief Technology Officer to Pursue New Career outside Biotech Industry

    Dr. Mariola Fotin-Mleczek will resign from CureVac

    18-Jan-2022 CureVac N.V. announced that the company’s Chief Technology Officer, Dr. Mariola Fotin-Mleczek, will resign from CureVac effective January 31, 2022. Mariola exits her role at CureVac after nearly 16 years of scientific leadership at the company, and 33 years in Germany, with plans to pursue ... more

    TTP Group reshuffles top management of Triplan Ingenieur AG

    06-Jan-2022 The Swiss Triplan Ingenieur AG, a subsidiary of TTP Group, has realigned its top management. As of January 1, 2022, Redjai Mamuti is the new Managing Director of Triplan Ingenieur AG, Switzerland. He takes over from Martin Scherrer, who has presided over the company as Interim Managing Dire ... more

    Change in SPECTRO Management

    Michael Privik Succeeds Dr. Christoph Mätzig

    05-Jan-2022 SPECTRO Analytical Instruments GmbH announced a change in management. Dr. Christoph Mätzig, who is moving within the AMETEK Group and has taken over the management of the Ultra Precision Technologies division effective January 1st, 2022, will be succeeded by Michael Privik, who has been a m ... more

  • Finances

    PreOmics announces early investors’ exit and closing of Series B financing

    Bruker is now a majority investor in PreOmics

    19-Jan-2022 PreOmics GmbH, a Martinsried, Germany-based developer of innovative automation and sample preparation tools and consumables for unbiased, deep proteomics analysis by mass spectrometry, has raised €13.5m in a Series B financing round provided by Bruker Corporation. PreOmics was founded in 20 ... more

    Lifespin secures bridge financing

    Artificial intelligence to determine health status and diagnose diseases

    18-Jan-2022 Lifespin GmbH in BioPark Regensburg has successfully concluded bridge financing to a total of € 2.5 million. The diagnostic data company is working successfully on an AI-based health platform that can measure important metabolic parameters in patients and expects to start series A in the fu ... more

    A spray to protect against lung damage from Covid-19

    Startup develop an RNA-based drug

    18-Jan-2022 rnatics, a startup at the Technical University of Munich (TUM), has created an RNA-based drug to prevent lung damage from infections as seen in serious Covid-19 cases. The Federal Ministry of Education and Research (BMBF) is providing 7 million euros in funding to support the development of ... more

  • Cooperation

    The two startups NeoCura and PhoreMost announce research collaboration to explore novel cancer therapeutics

    19-Jan-2022 NeoCura Bio-Medical Technology Co., Ltd., a RNA-based drug research and development company in China, and PhoreMost Limited, the UK-based biopharmaceutical company dedicated to ‘Drugging the Undruggable®’, announced an oncology drug discovery research collaboration As part of the collaborat ... more

    Evotec and Lilly enter into drug discovery collaboration in metabolic diseases

    Lilly has the right to select up to five programmes

    19-Jan-2022 Evotec SE announced that the Company has entered into a drug discovery collaboration with Eli Lilly and Company in the field of metabolic diseases with a focus on kidney diseases and diabetes.  The collaboration leverages Evotec’s extensive experience and track record of delivering in the f ... more

    BioNTech and Crescendo Biologics Announce Global Collaboration to Develop Multi-specific Precision Immunotherapies

    Crescendo will receive $40 million upfront, including a cash payment and an equity investment from BioNTech

    11-Jan-2022 BioNTech SE and Crescendo Biologics Ltd, a clinical stage immuno-oncology company developing novel, targeted T cell enhancing therapeutics, announced that they have entered a multi-target discovery collaboration to develop novel immunotherapies for the treatment of patients with cancer and ... more

  • Technology

    World's first toxicology testing strategy without animal testing adopted by OECD

    Success for long-standing collaboration between BASF and Givaudan to develop and validate alternative methods

    30-Jun-2021 The world’s first toxicology testing strategy without animal testing has been approved by the OECD (Organisation for Economic Co-operation and Development). The testing strategy consists of three so-called alternative methods. They can be used to predict whether a substance causes allergic ... more

    Evonik makes follow-on investment into In Ovo to support launch of gender-testing machine for eggs

    Biotechnology start-up reaches commercialization stage for its technology

    06-Apr-2021 Evonik has made a follow-up investment in the biotechnology start-up In Ovo through its venture capital unit. The investment comes as the young company reaches the commercialization stage for its technology and is bringing its gender-testing machine for eggs to the market. Together with co- ... more

    High-tech start-ups benefit from Twitter hype

    Study shows correlation between Twitter sentiment and the valuation of start-ups by venture capitalists

    18-Feb-2021 The short message service Twitter has played a prominent role in US politics in recent weeks and months and attracted a lot of attention. Even in business, Twitter users' tweets are being closely followed and used as a basis for decision-making. A new study shows that venture capitalists ca ... more

  • Laws

    Japan and Singapore Grant CRISPR Patents to Merck

    27-Nov-2019 Merck announced that the Japan Patent Office and the Intellectual Property Office of Singapore have each allowed the company’s patent application for the use of paired CRISPR nickases, bringing Merck’s number of patents to 22 worldwide. “Paired nickases represent a significant step in incre ... more

    Restriction of hazardous substances in tattoo inks

    15-Mar-2019 ECHA’s Committee for Socio-economic Analysis (SEAC) adopted its final opinion supporting the proposal by Denmark, Italy, Norway and ECHA to restrict the placing on the market of tattoo inks and permanent make-up. Substances within the scope of the restriction include carcinogenic, mutagenic ... more

    Merck Awarded Canadian CRISPR Nickase Patent for Foundational Genome-Editing Technology

    05-Mar-2019 Merck announced that the Canadian Patent Office has allowed Merck’s patent application directed to the use of paired CRISPR nickases in eukaryotic cells. The patent provides an important and more specific solution for scientists who need accurate methods when developing treatments for diffi ... more

  • Market

    M&A in chemicals and life sciences slowed down by global lockdowns

    Race for COVID-19 vaccine

    13-Jul-2020 In the first half of this year, the transaction volume of mergers and acquisitions in the chemical and life sciences industries has decreased dramatically. The volume of deals announced in the first six months is only $84 billion. Compared to the previous year (389 billion dollars), this is ... more

    Many of the deadliest cancers receive the least amount of research funding

    'Embarrassing' or stigmatized cancers like lung and liver are underfunded

    23-Jul-2019 Many of the deadliest or most common cancers get the least amount of nonprofit research funding, according to a new Northwestern Medicine study that examined the distribution of nonprofit research funding in 2015 across cancer types. Colon, endometrial, liver and bile duct, cervical, ovaria ... more

    Gene Editing Tools Gain an Uptick in Sales With Emphasis on Rare Genetic Disorder Management

    22-Jul-2019 According to latest research by FMI, the global gene editing tools market is estimated to have accounted for more than US$ 258 Mn in terms of value in 2018. The report on the gene editing tools market further projects that the gene editing tools market is likely to grow at a CAGR of over 18 ... more

  • Politics

    What the Biden-Harris administration means for chemistry

    The new administration has inherited a global pandemic and worsening climate change, among other science-related issues

    10-Feb-2021 The inauguration of Joe Biden and Kamala Harris marks a new era for science policy in the U.S. and beyond. The new administration has inherited a global pandemic and worsening climate change, among other science-related issues. A cover story in Chemical & Engineering News (C&EN), the weekly ... more

    Restriction of hazardous substances in tattoo inks

    15-Mar-2019 ECHA’s Committee for Socio-economic Analysis (SEAC) adopted its final opinion supporting the proposal by Denmark, Italy, Norway and ECHA to restrict the placing on the market of tattoo inks and permanent make-up. Substances within the scope of the restriction include carcinogenic, mutagenic ... more

    ECETOC Task Force provides new insights

    Toxicity testing of microparticles and poorly soluble liquids in the water environment

    15-Jan-2019 A Task Force set up by the European Centre for Ecotoxicology and Toxicology of Chemicals (ECETOC) has provided new insights into scientific testing for the impact of undissolved particles in the aquatic environment. ECETOC launched the Task Force in response to increasing concerns among the ... more

  • Manufacturing

    Covestro and Genomatica produce important chemical raw material using biotechnology

    Breakthrough for HMDA, widely-used ingredient, paves the way for more sustainable coatings, apparel, adhesives and plastics

    21-Jan-2022 Material manufacturer Covestro and biotechnology pioneer Genomatica announced an important industry milestone to advance sustainability resulting from their partnership. The two companies have teamed to be the first to successfully produce significant volumes of a plant-based version of the ... more

    Vetter’s new clinical manufacturing site now officially authorized

    Additional filling capacities for early-stage clinical development

    20-Jan-2022 Vetter has received the manufacturing authorization for its new site in Rankweil, Austria. As a result of the successful inspection held by the responsible national regulatory authority, the Austrian Agency for Health and Food Safety (AGES), the site can now support clinical development pro ... more

    Evonik builds world's first industrial-scale production plant for rhamnolipids

    Fermentation of sugar replaces petrochemical raw materials

    18-Jan-2022 Evonik is investing a three-digit million-euro sum in the construction of a new production plant for bio-based and fully biodegradable rhamnolipids. The decision to build the plant follows a breakthrough in Evonik's research and development. Rhamnolipids are biosurfactants and serve as acti ... more

  • Career

    Eppendorf with worldwide setting program

    Around 250 vacancies at all locations by the end of 2019

    26-Apr-2019 The Eppendorf Group is creating around 250 new jobs worldwide this year. A large proportion of the new jobs will be created in Hamburg at the headquarters of the globally active life sciences company and is an important component of Eppendorf's growth strategy. "Eppendorf is growing strongl ... more

    Lower pension, shorter life

    12-Apr-2019 Income and social status have an increasing effect on life expectancy in Germany. On average, men with very low retirement pay die five years earlier than those who are much better off. Poverty shortens life. According to a study by researchers at the Max Planck Institute for Demographic Re ... more

    KNAUER among the top one percent of employers in Germany

    28-Feb-2019 In the study "Leading Employers Germany 2019", the Berlin-based manufacturer of high-tech laboratory measuring instruments KNAUER was ranked as one of the best employers for the second time. This makes KNAUER one of the companies with the best ratings in an independent meta-study conducted ... more

News according to country
News archive
Newsletters

bionity.com Newsletter

The bionity.com newsletter keeps you informed about the current events in the fields of biotechnology, life sciences and medicine with news, products, company profiles and technical information.
Current edition

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE